These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27553089)

  • 1. Prognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.
    Paluszczak J; Wiśniewska D; Kostrzewska-Poczekaj M; Kiwerska K; Grénman R; Mielcarek-Kuchta D; Jarmuż-Szymczak M
    Clin Oral Investig; 2017 Jun; 21(5):1777-1788. PubMed ID: 27553089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent methylation of DAB2, a Wnt pathway antagonist, in oral and oropharyngeal squamous cell carcinomas.
    Paluszczak J; Kiwerska K; Mielcarek-Kuchta D
    Pathol Res Pract; 2018 Feb; 214(2):314-317. PubMed ID: 29254794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and epigenetic regulation of DACT1 and DACT2 in oral squamous cell carcinoma.
    Schussel JL; Kalinke LP; Sassi LM; de Oliveira BV; Pedruzzi PA; Olandoski M; Alvares LE; Garlet GP; Trevilatto PC
    Cancer Biomark; 2015; 15(1):11-7. PubMed ID: 25524937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers.
    Huang RL; Gu F; Kirma NB; Ruan J; Chen CL; Wang HC; Liao YP; Chang CC; Yu MH; Pilrose JM; Thompson IM; Huang HC; Huang TH; Lai HC; Nephew KP
    Epigenetics; 2013 Jun; 8(6):624-34. PubMed ID: 23774800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.
    Zhang M; Linghu E; Zhan Q; He T; Cao B; Brock MV; Herman JG; Xiang R; Guo M
    Oncotarget; 2016 Apr; 7(14):17957-69. PubMed ID: 26919254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
    Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
    J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential promoter usages of PTCH1 and down regulation of HHIP are associated with HNSCC progression.
    Chakraborty B; Basu M; Mukhopadhyay D; Alam N; Ghosh S; Dutta S; Panda CK
    Pathol Res Pract; 2022 Apr; 232():153827. PubMed ID: 35276608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
    Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
    Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.
    Zhang X; Yang Y; Liu X; Herman JG; Brock MV; Licchesi JD; Yue W; Pei X; Guo M
    Epigenetics; 2013 Apr; 8(4):373-82. PubMed ID: 23449122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of DACT2, a key component of the Wnt signalling pathway in human lung cancer.
    Jia Y; Yang Y; Brock MV; Zhan Q; Herman JG; Guo M
    J Pathol; 2013 Jun; 230(2):194-204. PubMed ID: 22806826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers.
    Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
    Oral Dis; 2011 Nov; 17(8):794-800. PubMed ID: 21819494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.